Picks for Fri, Nov 6
Stock picks. Minted before the open.
Thesis
- EPS beat +218.1% on the latest report.
- Quarter over quarter EPS growth +122.0%.
- Price $13.12 is above the 20, 50, and 200 day moving averages ($11.61, $11.37, $12.41).
- RSI 14 at 66.0: momentum without being deeply overbought.
- Relative volume 2.92x the 50 day average.
Entry
Buy at limit $13.12 or better.
Sizing
Risk rule: 2% of portfolio per idea. Example: a $100,000 portfolio supports about 1905 shares (2% risk with an 8% stop).
Exit plan
Stop: exit below $12.07 (8% under entry).
Time exit: reassess by Dec 21, 2026 (45 days) or at the next earnings report, whichever comes first.
Thesis
- EPS beat +247.6% on the latest report.
- Quarter over quarter EPS growth +125.0%.
- Price $48.73 is above the 20, 50, and 200 day moving averages ($48.54, $46.76, $35.42).
- RSI 14 at 54.6: momentum without being deeply overbought.
- Relative volume 1.42x the 50 day average.
Entry
Buy at limit $48.73 or better.
Sizing
Risk rule: 2% of portfolio per idea. Example: a $100,000 portfolio supports about 513 shares (2% risk with an 8% stop).
Exit plan
Stop: exit below $44.83 (8% under entry).
Time exit: reassess by Dec 21, 2026 (45 days) or at the next earnings report, whichever comes first.
Thesis
- EPS beat +41.9% on the latest report.
- Quarter over quarter EPS growth +84.6%.
- Price $107.65 is above the 20, 50, and 200 day moving averages ($103.15, $100.37, $91.57).
- RSI 14 at 66.2: momentum without being deeply overbought.
- Relative volume 2.80x the 50 day average.
Entry
Buy at limit $107.65 or better.
Sizing
Risk rule: 2% of portfolio per idea. Example: a $100,000 portfolio supports about 232 shares (2% risk with an 8% stop).
Exit plan
Stop: exit below $99.04 (8% under entry).
Time exit: reassess by Dec 21, 2026 (45 days) or at the next earnings report, whichever comes first.
Thesis
- EPS beat +108.9% on the latest report.
- Quarter over quarter EPS growth +100.9%.
- Price $160.37 is above the 20, 50, and 200 day moving averages ($155.64, $155.15, $128.26).
- RSI 14 at 64.5: momentum without being deeply overbought.
- Relative volume 1.80x the 50 day average.
Entry
Buy at limit $160.37 or better.
Sizing
Risk rule: 2% of portfolio per idea. Example: a $100,000 portfolio supports about 155 shares (2% risk with an 8% stop).
Exit plan
Stop: exit below $147.54 (8% under entry).
Time exit: reassess by Dec 21, 2026 (45 days) or at the next earnings report, whichever comes first.
Thesis
- EPS beat +9.1% on the latest report.
- Quarter over quarter EPS growth +63.4%.
- Price $80.37 is above the 20, 50, and 200 day moving averages ($76.24, $74.74, $78.27).
- RSI 14 at 65.2: momentum without being deeply overbought.
- Relative volume 2.90x the 50 day average.
Entry
Buy at limit $80.37 or better.
Sizing
Risk rule: 2% of portfolio per idea. Example: a $100,000 portfolio supports about 311 shares (2% risk with an 8% stop).
Exit plan
Stop: exit below $73.94 (8% under entry).
Time exit: reassess by Dec 21, 2026 (45 days) or at the next earnings report, whichever comes first.